recurrent prostate cancer
Showing 51 - 75 of 92
Prostate Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (laboratory biomarker
Completed
- Prostate Cancer
- +3 more
- laboratory biomarker analysis
- +2 more
-
Los Angeles, CaliforniaUniversity of Southern California
Jul 5, 2017
Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Los Angeles (abiraterone
Unknown status
- Hormone-resistant Prostate Cancer
- +2 more
- abiraterone acetate
- +2 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Jul 5, 2017
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Portland (drug, dietary
Terminated
- Adenocarcinoma of the Prostate
- +3 more
- abiraterone acetate
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 26, 2017
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer Trial in Portland (Sulforaphane, Laboratory biomarker analysis,
Completed
- Adenocarcinoma of the Prostate
- Recurrent Prostate Cancer
- Sulforaphane
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 26, 2017
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Rochester (tanespimycin, laboratory
Completed
- Adenocarcinoma of the Prostate
- +2 more
- tanespimycin
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Mar 20, 2017
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco (ixabepilone,
Completed
- Adenocarcinoma of the Prostate
- +2 more
- ixabepilone
- +2 more
-
San Francisco, CaliforniaUCSF Helen Diller Family Comprehensive Cancer Center
Feb 21, 2017
Prostate Cancer, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer Trial in Orange (sunitinib malate, docetaxel,
Terminated
- Prostate Cancer
- +5 more
- sunitinib malate
- +2 more
-
Orange, CaliforniaChao Comprehensive Cancer Center
Dec 6, 2016
Recurrent Prostate Cancer Trial in Baltimore (Testosterone cypionate, Goserelin, Leuprolide)
Completed
- Recurrent Prostate Cancer
- Testosterone cypionate
- +2 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 10, 2016
Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Seattle (radiation, procedure,
Withdrawn
- Hormone-resistant Prostate Cancer
- +2 more
- carbon-11 acetate
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Aug 29, 2016
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Ann Arbor (cilengitide)
Completed
- Recurrent Prostate Cancer
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Mar 28, 2016
Recurrent Prostate Cancer Trial in Chicago, Madison (pazopanib HCl, leuprolide acetate, goserelin acetate)
Completed
- Recurrent Prostate Cancer
- pazopanib hydrochloride
- +2 more
-
Chicago, Illinois
- +1 more
Jan 8, 2016
Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer Trial in Sutton Surrey (onapristone,
Unknown status
- Prostate Cancer
- +3 more
-
Sutton Surrey, United KingdomInst of Cancer Research & Royal Marsden NHS Foundation Trust
Jun 22, 2015
Salvage Cryotherapy in Recurrent Prostate Cancer
Terminated
- Recurrent Prostate Cancer
- Cryoablation / Cryotherapy
-
Loma Linda, California
- +16 more
May 26, 2015
Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in United States (saracatinib,
Terminated
- Hormone-resistant Prostate Cancer
- +2 more
- saracatinib
- hydrocortisone/placebo
-
Chicago, Illinois
- +14 more
Mar 18, 2015
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Cleveland (linsitinib,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- linsitinib
- laboratory biomarker analysis
-
Cleveland, Ohio
- +1 more
Mar 2, 2015
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIB Prostate Cancer Trial in Sacramento (perifosine, laboratory
Terminated
- Adenocarcinoma of the Prostate
- +4 more
- perifosine
- laboratory biomarker analysis
-
Sacramento, CaliforniaUC Davis Cancer Center
Feb 9, 2015
Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (cabazitaxel, prednisone, octreotide
Terminated
- Diarrhea
- +7 more
- cabazitaxel
- +4 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Nov 21, 2014
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Philadelphia (lapatinib ditosylate,
Completed
- Recurrent Prostate Cancer
- +4 more
- lapatinib ditosylate
- laboratory biomarker analysis
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Sep 19, 2014
Bone Metastases, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Boston (procedure, radiation, other)
Completed
- Bone Metastases
- +6 more
- magnetic resonance imaging
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 1, 2014
Adenocarcinoma of the Prostate, Hormone-refractory Prostate Cancer, Recurrent Prostate Cancer Trial in United States (eribulin
Completed
- Adenocarcinoma of the Prostate
- +3 more
- eribulin mesylate
-
Scottsdale, Arizona
- +146 more
May 21, 2014
Recurrent Prostate Cancer, Stage IV Prostate Cancer, Solid Tumor Trial in New York (tanespimycin, docetaxel)
Completed
- Recurrent Prostate Cancer
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 16, 2014
Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Ann Arbor (vorinostat, laboratory biomarker analysis)
Completed
- Recurrent Prostate Cancer
- Stage IV Prostate Cancer
- vorinostat
- laboratory biomarker analysis
-
Ann Arbor, MichiganUniversity of Michigan
Apr 25, 2014
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in United States (ixabepilone)
Completed
- Adenocarcinoma of the Prostate
- +2 more
-
Aurora, Colorado
- +161 more
Apr 21, 2014
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Haven, Chicago (drug,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- docetaxel
- +4 more
-
New Haven, Connecticut
- +1 more
Apr 21, 2014
Stage IV Prostate Cancer, Bone Metastases, Adenocarcinoma of the Prostate Trial run by the NCI (alendronate sodium,
Terminated
- Stage IV Prostate Cancer
- +3 more
- alendronate sodium
- ketoconazole
-
Bethesda, MarylandMedicine Branch
Apr 21, 2014